WALPAR NUTRITIONS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 112.6 INR | -3.55% |
|
-12.71% | +36.24% |
| 2023 | Walpar Nutritions Limited Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
| 2023 | Walpar Nutritions Limited Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
Valuation
| Fiscal Period: March | 2022 | 2023 |
|---|---|---|
| Capitalization 1 | 122.6 | 229.3 |
| Enterprise Value (EV) 1 | 190.5 | 326.9 |
| P/E ratio | 29.9 x | 38.9 x |
| Yield | - | - |
| Capitalization / Revenue | 0.46 x | 0.65 x |
| EV / Revenue | 0.71 x | 0.92 x |
| EV / EBITDA | 18.3 x | 8.57 x |
| EV / FCF | -35,41,737 x | -63,89,720 x |
| FCF Yield | -0% | -0% |
| Price to Book | 1.12 x | 1.96 x |
| Nbr of stocks (in thousands) | 4,541 | 4,541 |
| Reference price 2 | 27.00 | 50.50 |
| Announcement Date | 23/08/22 | 06/10/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 64.45 | 128.2 | 167.1 | 182 | 267.7 | 353.6 |
| EBITDA 1 | 4.094 | 8.015 | 12.08 | 13.71 | 10.4 | 38.14 |
| EBIT 1 | 2.041 | 5.512 | 9.149 | 10.32 | 7.761 | 19.34 |
| Operating Margin | 3.17% | 4.3% | 5.47% | 5.67% | 2.9% | 5.47% |
| Earnings before Tax (EBT) 1 | 0.275 | 1.182 | 1.901 | 4.898 | 2.733 | 11.11 |
| Net income 1 | 0.033 | 0.688 | 1.218 | 4.506 | 3.807 | 5.901 |
| Net margin | 0.05% | 0.54% | 0.73% | 2.48% | 1.42% | 1.67% |
| EPS 2 | 0.0100 | 0.2293 | 0.4060 | 1.380 | 0.9038 | 1.299 |
| Free Cash Flow | - | -22.26 | -23.69 | -74.1 | -53.79 | -51.17 |
| FCF margin | - | -17.36% | -14.17% | -40.7% | -20.09% | -14.47% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 15/06/21 | 15/06/21 | 15/06/21 | 30/10/21 | 23/08/22 | 06/10/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 11.8 | 32.2 | 50.5 | 65.1 | 67.9 | 97.6 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.893 x | 4.013 x | 4.184 x | 4.753 x | 6.532 x | 2.559 x |
| Free Cash Flow | - | -22.3 | -23.7 | -74.1 | -53.8 | -51.2 |
| ROE (net income / shareholders' equity) | - | 7.38% | 8.09% | 13.4% | 4.09% | 6.18% |
| ROA (Net income/ Total Assets) | - | 5.27% | 5.12% | 4.12% | 2.1% | 3.88% |
| Assets 1 | - | 13.07 | 23.81 | 109.5 | 180.9 | 152.3 |
| Book Value Per Share 2 | 2.600 | 3.610 | 6.420 | 14.30 | 24.20 | 25.80 |
| Cash Flow per Share 2 | 1.230 | 2.820 | 1.650 | 2.920 | 1.020 | 1.180 |
| Capex 1 | 5.12 | 3.2 | 4.82 | 55.9 | 38.4 | 52.4 |
| Capex / Sales | 7.94% | 2.49% | 2.89% | 30.7% | 14.36% | 14.83% |
| Announcement Date | 15/06/21 | 15/06/21 | 15/06/21 | 30/10/21 | 23/08/22 | 06/10/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +36.24% | 6.35M | |
| -.--% | 843M | |
| +30.38% | 461M | |
| +38.59% | 258M | |
| 0.00% | 133M | |
| +93.48% | 53.9M |
- Stock Market
- Equities
- WALPAR Stock
- Financials Walpar Nutritions Limited
